BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28395748)

  • 21. Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutation.
    Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
    Stem Cell Res; 2016 Nov; 17(3):657-660. PubMed ID: 27934602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of non-integrated induced pluripotent stem cells from a 59-year-old female with multiple endocrine neoplasia type 1 syndrome.
    Guo D; Wu F; Liu H; Gao G; Kou S; Yang F; Abbas N; Zhou T; Cai X; Zhang H; Qin D; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jan; 18():64-66. PubMed ID: 28395808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.
    Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P
    PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy.
    Ross SB; Fraser ST; Bagnall RD; Semsarian C
    Stem Cell Res; 2017 Apr; 20():76-79. PubMed ID: 28395744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1.
    Jung-Klawitter S; Ebersold J; Göhring G; Blau N; Opladen T
    Stem Cell Res; 2017 Apr; 20():38-41. PubMed ID: 28395739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of Mucopolysaccharidosis type II (MPS II) disorder.
    Varga E; Nemes C; Kovács E; Bock I; Varga N; Fehér A; Dinnyés A; Kobolák J
    Stem Cell Res; 2016 Nov; 17(3):514-516. PubMed ID: 27789401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Derivation of human iPSC line NCCSi002-A from umbilical cord blood (UCB) CD34+cells of donor from Indian ethnicity.
    Fernandes S; Shinde P; Khan N; Singh S; Vardhan S; Nair V; Kale V; Limaye L
    Stem Cell Res; 2018 Jan; 26():80-83. PubMed ID: 29268156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of an induced pluripotent stem cell (iPSC) line from a patient with Clozapine-responder Schizophrenia.
    Marcatili M; Marsoner F; D'Agostino A; Karnavas T; Bottai D; Scarone S; Conti L
    Stem Cell Res; 2016 Nov; 17(3):630-633. PubMed ID: 27934596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of human control iPS cell line CHOPWT10 from healthy adult peripheral blood mononuclear cells.
    Maguire JA; Gagne AL; Jobaliya CD; Gandre-Babbe S; Gadue P; French DL
    Stem Cell Res; 2016 Mar; 16(2):338-41. PubMed ID: 27345999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation and characterization of an induced pluripotent stem cell (iPSC) line from a patient with clozapine-resistant Schizophrenia.
    Marsoner F; Marcatili M; Karnavas T; Bottai D; D'Agostino A; Scarone S; Conti L
    Stem Cell Res; 2016 Nov; 17(3):661-664. PubMed ID: 27934603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene.
    Ross SB; Fraser ST; Nowak N; Semsarian C
    Stem Cell Res; 2017 Apr; 20():88-90. PubMed ID: 28395747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors.
    Ye L; Muench MO; Fusaki N; Beyer AI; Wang J; Qi Z; Yu J; Kan YW
    Stem Cells Transl Med; 2013 Aug; 2(8):558-66. PubMed ID: 23847002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
    Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
    Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of a human induced pluripotent stem cell line from urinary cells of a healthy donor using an integration free vector.
    Rossbach B; Hildebrand L; El-Ahmad L; Stachelscheid H; Reinke P; Kurtz A
    Stem Cell Res; 2016 Mar; 16(2):314-7. PubMed ID: 27345993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of a clonal induced pluripotent stem cell (iPSC) line expressing the mutant MECP2 allele from a Rett Syndrome patient fibroblast line.
    Hunihan L; Brown J; Cacace A; Fernandes A; Weston A
    Stem Cell Res; 2017 Apr; 20():67-69. PubMed ID: 28395743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphoblast-derived integration-free iPS cell line from a female 67-year-old Alzheimer's disease patient with TREM2 (R47H) missense mutation.
    Schröter F; Sleegers K; Cuyvers E; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2016 Nov; 17(3):553-555. PubMed ID: 27789408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of MUi009 - A human induced pluripotent stem cells from a 32year old male with homozygous β°-thalassemia coinherited with heterozygous α-thalassemia 2.
    Wongkummool W; Maneepitasut W; Tong-Ngam P; Tangprasittipap A; Munkongdee T; Boonchuay C; Svasti S; Kitiyanant N; Paiboonsukwong K; Fucharoen S; Tubsuwan A
    Stem Cell Res; 2017 Apr; 20():80-83. PubMed ID: 28395745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of human induced pluripotent stem cell (iPSC) line from a 72year old male patient with later onset Alzheimer's disease.
    Zhang S; Lv Z; Zhang S; Liu L; Li Q; Gong W; Sha H; Wu H
    Stem Cell Res; 2017 Mar; 19():34-36. PubMed ID: 28413002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
    Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
    Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of an iPSC line from a patient with tyrosine hydroxylase (TH) deficiency: TH-1 iPSC.
    Jung-Klawitter S; Blau N; Sebe A; Ebersold J; Göhring G; Opladen T
    Stem Cell Res; 2016 Nov; 17(3):580-583. PubMed ID: 27934587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.